Clinical Efficacy of Yiqi Yangyin Decoction Combined with Adjuvant Chemotherapy on the Postoperative Life Quality of Breast Cancer

References

• Wöckel A, Albert U-S, Janni W, Scharl A, Kreienberg R, Stüber T. The screening, diagnosis, treatment, and follow-up of breast cancer. Dtsch Arztebl Int. 2018;115(18):316–23. doi:10.3238/arztebl.2018.0316
   PubMed Web of Science ®Google Scholar
• McDonald ES, Clark AS, Tchou J, Zhang P, Freedman GM. Clinical diagnosis and management of breast cancer. J Nucl Med. 2016;57 Suppl 1(Supplement 1):9S–16S. doi:10.2967/jnumed.115.157834
   PubMedGoogle Scholar
• Al-Hilli Z, Wilkerson A. Breast surgery: management of postoperative complications following operations for breast cancer. Surg Clin North Am. 2021;101(5):845–63. doi:10.1016/j.suc.2021.06.014
   PubMed Web of Science ®Google Scholar
• Sagona A, Gentile D, Anghelone CAP, Barbieri E, Marrazzo E, Antunovic L, et al. Ipsilateral breast cancer recurrence: characteristics, treatment, and long-term oncologic results at a high-volume center. Clin Breast Cancer. 2021;21(4):329–36.
   PubMed Web of Science ®Google Scholar
• Al-Hilli Z, Boughey JC. The timing of breast and axillary surgery after neoadjuvant chemotherapy for breast cancer. Chin Clin Oncol. 2016;5(3):37–doi:10.21037/cco.2016.03.26
   PubMed Web of Science ®Google Scholar
• Pondé NF, Zardavas D, Piccart M. Progress in adjuvant systemic therapy for breast cancer. Nat Rev Clin Oncol. 2019;16(1):27–44. doi:10.1038/s41571-018-0089-9
   PubMed Web of Science ®Google Scholar
• Provenzano E. Neoadjuvant chemotherapy for breast cancer: moving beyond pathological complete response in the molecular age. Acta Med Acad. 2021;50(1):88–109. doi:10.5644/ama2006-124.328
   PubMedGoogle Scholar
• Xue JX, Zhu ZY, Bian WH, Yao C. The traditional Chinese Medicine Kangai Injection as an adjuvant method in combination with chemotherapy for the treatment of breast cancer in Chinese patients: a meta-analysis. Evidence-Based Complementary and Alternativ Med: eCAM. 2018;2018:1–16. doi:10.1155/2018/6305645
   Web of Science ®Google Scholar
• Zhang C, Guo W, Yao X, Xia J, Zhang Z, Li J, Chen H, Lin L. Database mining and animal experiment-based validation of the efficacy and mechanism of Radix Astragali (Huangqi) and Rhizoma Atractylodis Macrocephalae (Baizhu) as core drugs of Traditional Chinese medicine in cancer-related fatigue. J Ethnopharmacol. 2022;285:114892. doi:10.1016/j.jep.2021.114892
   PubMed Web of Science ®Google Scholar
• Chien TJ, Song YL, Lin CP, Hsu CH. The correlation of traditional Chinese medicine deficiency syndromes, cancer related fatigue, and quality of life in breast cancer patients. J Tradit Complement Med. 2012;2(3):204–10. doi:10.1016/s2225-4110(16)30101-8
   PubMedGoogle Scholar
• Wang F, Hua BJ. Treatment of malignant thymoma patients with Qi-blood deficiency after surgery using protecting Pi and Wei, strengthening body resistance to consolidate constitution method: case Report of One Case. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016;36(4):497–8.
   PubMedGoogle Scholar
• Li F, Liu G, Xue P, Ren Z, Dai P, Niu W, Xin M. YiQi YangYin decoction attenuates nonalcoholic fatty liver disease in type 2 diabetes rats. Evidence-Based Complementary and Alternative Med: eCAM. 2021;2021:1–19. doi:10.1155/2021/5511019
   Web of Science ®Google Scholar
• Li Q, Zhang Q, Liu Y, Zhao S, Zhang B, Xie B. Efficacy of Yiqi Yangyin Jiedu decoction in postoperative patients with thyroid cancer: a protocol for systematic review and meta-analysis. Medicine (Baltimore). 2022;101(50):e31803. doi:10.1097/MD.0000000000031803
   PubMed Web of Science ®Google Scholar
• Yao J, Lu Y, Jiao L, Bi L, Yang W, Su L, Shi J, Wang Z, Gong Y, Xu L, et al. Chinese herbal medicine (Yiqi-Yangyin-Jiedu decoction) combined with osimertinib as first-line treatment in EGFR mutation-positive advanced non-small-cell lung cancer (CATLA-2): a study protocol for a double-blind randomized controlled trial. Front Pharmacol. 2022;13:840889. doi:10.3389/fphar.2022.840889
   PubMedGoogle Scholar
• Zhou C, Li Q, Lu S, Zhang Z. Effect of Yiqi Yangyin prescription in treatment of dilated cardiomyopathy: a Meta-analysis of randomized controlled trials. J Tradit Chin Med. 2017;37(4):421–30.
   PubMed Web of Science ®Google Scholar
• Li CX, Liu Y, Zhang YZ, Li JC, Lai J. Astragalus polysaccharide: a review of its immunomodulatory effect. Arch Pharm Res. 2022;45(6):367–89. doi:10.1007/s12272-022-01393-3
   PubMed Web of Science ®Google Scholar
• Xu J, Chen D, Liu C, Wu XZ, Dong CX, Zhou J. Structural characterization and anti-tumor effects of an inulin-type fructan from Atractylodes chinensis. Int J Biol Macromol. 2016;82:765–71. doi:10.1016/j.ijbiomac.2015.10.082
   PubMed Web of Science ®Google Scholar
• Amin A, Hossen MJ, Fu X-Q, Chou J-Y, Wu J-Y, Wang X-Q, Chen Y-J, Wu Y, Yin C-L, Dou X-B, et al. Inhibition of the Akt/NF-kappaB pathway is involved in the anti-gastritis effects of an ethanolic extract of the rhizome of Atractylodes macrocephala. J Ethnopharmacol. 2022;293:115251. doi:10.1016/j.jep.2022.115251
   PubMed Web of Science ®Google Scholar
• Fu J, Wang Z, Huang L, Zheng S, Wang D, Chen S, Zhang H, Yang S. Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi). Phytother Res: PTR. 2014;28(9):1275–83. doi:10.1002/ptr.5188
   PubMed Web of Science ®Google Scholar
• Sheik A, Kim K, Varaprasad GL, Lee H, Kim S, Kim E, Shin J-Y, Oh SY, Huh YS. The anti-cancerous activity of adaptogenic herb Astragalus membranaceus. Phytomedicine. 2021;91:153698. doi:10.1016/j.phymed.2021.153698
   PubMed Web of Science ®Google Scholar
• Auyeung KK, Han QB, Ko JK. Astragalus membranaceus: a review of its protection against inflammation and gastrointestinal cancers. Am J Chin Med. 2016;44(1):1–22. doi:10.1142/S0192415X16500014
   PubMed Web of Science ®Google Scholar
• Ruqiao L, Yueli C, Xuelan Z, Huifen L, Xin Z, Danjie Z, Le S, Yanxue Z. Rhizoma Atractylodis macrocephalae: a review of photochemistry, pharmacokinetics and pharmacology. Pharmazie. 2020;75(2):42–55. doi:10.1691/ph.2020.9738
   PubMed Web of Science ®Google Scholar
• Bailly C. Anticancer properties of lobetyolin, an essential component of radix codonopsis (Dangshen). Nat Prod Bioprospect. 2021;11(2):143–53. doi:10.1007/s13659-020-00283-9
   PubMed Web of Science ®Google Scholar
• Gu L, Zhang Y, Zhang S, Zhao H, Wang Y, Kan D, Zhang Y, Guo L, Lv J, Hao Q, et al. Coix lacryma-jobi seed oil reduces fat accumulation in nonalcoholic fatty liver disease by inhibiting the activation of the p-AMPK/SePP1/apoER2 pathway. J Oleo Sci. 2021;70(5):685–96. doi:10.5650/jos.ess20255
   PubMed Web of Science ®Google Scholar
• Son ES, Kim YO, Park CG, Park KH, Jeong SH, Park J-W, Kim S-H. Coix lacryma-jobi var. ma-yuen Stapf sprout extract has anti-metastatic activity in colon cancer cells in vitro. BMC Complement Altern Med. 2017;17(1):486. doi:10.1186/s12906-017-1990-y
   PubMedGoogle Scholar
• Liu LS, Liu JX, Li CJ. Clinical effect of yiqi yangyin jiedu decoction in treating patients with advanced non-small cell lung cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008;28(4):352–5.
   PubMedGoogle Scholar
• Jiao P, Wang Y, Ren G, Chu D, Li Y, Sang T. Integrating network pharmacology and experimental validation to elucidate the mechanism of Yiqi Yangyin decoction in suppressing non-small-cell lung cancer. Biomed Res Int. 2023;2023:4967544–23. doi:10.1155/2023/4967544
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Nat Cancer Instit. 1993;85(5):365–76.
   PubMed Web of Science ®Google Scholar
• Husson O, de Rooij BH, Kieffer J, Oerlemans S, Mols F, Aaronson NK, van der Graaf WTA, van de Poll-Franse LV. The EORTC QLQ-C30 summary score as prognostic factor for survival of patients with cancer in the "real-world": results from the population-based PROFILES registry. Oncologist. 2020;25(4):e722–e32. doi:10.1634/theoncologist.2019-0348
   PubMed Web of Science ®Google Scholar
• Goodman M. Managing the side effects of chemotherapy. Semin Oncol Nurs. 1989;5(2 Suppl 1):29–52. doi:10.1016/0749-2081(89)90080-6
   PubMedGoogle Scholar
• Hauner K, Maisch P, Retz M. Side effects of chemotherapy. Urologe A. 2017;56(4):472–9. doi:10.1007/s00120-017-0338-z
   PubMedGoogle Scholar
• Zraik IM, Heß-Busch Y. Management of chemotherapy side effects and their long-term sequelae. Urologe A. 2021;60(7):862–71. doi:10.1007/s00120-021-01569-7
   PubMedGoogle Scholar
• Huang Y, Yan S, Su Z, Xia L, Xie J, Zhang F, Du Z, Hou X, Deng J, Hao E, et al. Aquaporins: A new target for traditional Chinese medicine in the treatment of digestive system diseases. Front Pharmacol. 2022;13:1069310. doi:10.3389/fphar.2022.1069310
   PubMed Web of Science ®Google Scholar
• Lee HS, Lee IH, Park SI, Lee DY. Network pharmacology-based investigation of the system-level molecular mechanisms of the hematopoietic activity of Samul-Tang, a traditional Korean herbal formula. Evidence-Based Complementary and Alternativ Med: eCAM. 2020;2020:1–17. doi:10.1155/2020/9048089
   Web of Science ®Google Scholar
• Wang Y-Y, Zhou N, Shan Z-F, Ke Y-Y, Liu Z, Liu Z-H, Feng W-S, Zheng X-K. Metabolomic strategies and biochemical analysis of the effect of processed Rehmanniae radix extract on a blood-deficient rat model. BMC Complement Med Ther. 2022;22(1):89. doi:10.1186/s12906-022-03560-x
   PubMedGoogle Scholar
• Su EY, Fang YH, Chen HS. Clinical observation of treating 62 patients with severe aplastic anemia failing in immunosuppressive therapy by integrative medicine. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012;32(12):1616–20.
   PubMedGoogle Scholar